I
INDIVIOR PLC ORDINARY SHARES
NASDAQ: INDV (Indivior Pharmaceuticals, Inc.)
Last update: 2 hours ago39.80
-0.45 (-1.12%)
| Previous Close | 40.25 |
| Open | 40.14 |
| Volume | 1,450,982 |
| Avg. Volume (3M) | 1,967,287 |
| Market Cap | 4,704,542,208 |
| Price / Earnings (TTM) | 20.41 |
| Price / Earnings (Forward) | 12.82 |
| Price / Sales | 3.91 |
| Price / Book | 145.25 |
| 52 Weeks Range |
| Profit Margin | -5.30% |
| Operating Margin (TTM) | 25.56% |
| Diluted EPS (TTM) | -0.050 |
| Quarterly Revenue Growth (YOY) | -6.30% |
| Quarterly Earnings Growth (YOY) | -23.00% |
| Current Ratio (MRQ) | 0.880 |
| Operating Cash Flow (TTM) | 135.00 M |
| Levered Free Cash Flow (TTM) | 264.88 M |
| Return on Assets (TTM) | 12.60% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Indivior Pharmaceuticals, Inc. | Mixed | Bullish |
AIStockmoo Score
-0.1
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.5 |
| Average | -0.13 |
|
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| % Held by Insiders | 4.02% |
| % Held by Institutions | 89.09% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Oaktree Capital Management Lp | 31 Mar 2026 | 6,984,102 |
| Two Seas Capital Lp | 31 Mar 2026 | 4,746,510 |
| Fuller & Thaler Asset Management, Inc. | 31 Mar 2026 | 4,529,583 |
| Madison Avenue Partners, Lp | 31 Mar 2026 | 4,315,162 |
| Deerfield Management Company, L.P. | 31 Mar 2026 | 3,097,790 |
| Mangrove Partners Im, Llc | 31 Mar 2026 | 2,742,434 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HEIDBREDER CHRISTIAN | - | 40.50 | -18,586 | -752,733 |
| Aggregate Net Quantity | -18,586 | |||
| Aggregate Net Value ($) | -752,733 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 40.50 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HEIDBREDER CHRISTIAN | Officer | 10 Jul 2026 | Automatic sell (-) | 18,586 | 40.50 | 752,733 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |